The article discusses the success of the RESCEU and PROMISE initiatives, which are European public-private partnerships aimed at preventing respiratory syncytial virus (RSV). The RESCEU initiative, launched in 2017, focused on deepening understanding of RSV through collaboration between researchers and scientists from the public and private sectors. Despite the challenges posed by the COVID-19 pandemic, the initiative produced high-quality research that informed policy on RSV surveillance and recommendations for RSV vaccines and monoclonal antibodies. The PROMISE initiative, funded in 2021, aims to build on the achievements of RESCEU and address remaining key questions about RSV. The article highlights the need for continued collaboration in infectious disease prevention and control to develop life-saving interventions and ensure equitable access. [Extracted from the article]